• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新处理数据以形成质量调整生命年。

Reprocessing data to form QALYs.

作者信息

Coast J

机构信息

Department of Epidemiology and Public Health Medicine, University of Bristol.

出版信息

BMJ. 1992 Jul 11;305(6845):87-90. doi: 10.1136/bmj.305.6845.87.

DOI:10.1136/bmj.305.6845.87
PMID:1379096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1882639/
Abstract

OBJECTIVES

To determine whether reprocessing data from published sources into quality adjusted life years (QALYs), as recommended in The QALY Toolkit, is a useful method of helping purchasing authorities to determine the most cost effective pattern of care to buy for their populations.

SETTING

United Kingdom.

DESIGN

The method was tested for six elective surgical conditions; data from published studies were reprocessed into the Rosser index, to obtain values for change in quality of life. These were then used to form QALYs. A small validation exercise was carried out.

MAIN OUTCOME MEASURES

QALYs formed from the Rosser index.

RESULTS

Published data could not be found for three interventions (cataract surgery, inguinal hernia repair, varicose vein surgery). For the remainder (prostatectomy, hip replacement, and knee replacement) data were found which could be reprocessed to form QALYs, though it was often hard to compare data from different studies and many assumptions had to be made.

CONCLUSION

The value of QALY results obtained by this method is questionable, given the large number of assumptions which had to be made. For many interventions published data are unlikely to be available.

摘要

目的

按照《质量调整生命年工具包》中的建议,将已发表资料中的数据重新处理为质量调整生命年(QALY),以此判断这是否是一种有助于采购机构确定为其人群购买最具成本效益的护理模式的有用方法。

背景

英国。

设计

针对六种择期手术情况对该方法进行测试;将已发表研究中的数据重新处理为罗瑟指数,以获取生活质量变化值。然后用这些值来形成质量调整生命年。开展了一项小型验证工作。

主要观察指标

由罗瑟指数形成的质量调整生命年。

结果

未找到三种干预措施(白内障手术、腹股沟疝修补术、静脉曲张手术)的已发表数据。对于其余的(前列腺切除术、髋关节置换术和膝关节置换术),找到了可以重新处理以形成质量调整生命年的数据,不过通常很难比较不同研究的数据,且不得不做出许多假设。

结论

鉴于必须做出大量假设,通过该方法获得的质量调整生命年结果的价值值得怀疑。对于许多干预措施,不太可能获得已发表的数据。

相似文献

1
Reprocessing data to form QALYs.重新处理数据以形成质量调整生命年。
BMJ. 1992 Jul 11;305(6845):87-90. doi: 10.1136/bmj.305.6845.87.
2
Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.与髋或膝关节骨关节炎相比,手术治疗局限性腰椎椎管狭窄症的比较结果和成本效用:第 2 部分——估计终生增量成本效用比。
Spine J. 2014 Feb 1;14(2):244-54. doi: 10.1016/j.spinee.2013.11.011. Epub 2013 Nov 12.
3
Cost-utility analysis.成本效用分析
BMJ. 1993 Oct 2;307(6908):859-62. doi: 10.1136/bmj.307.6908.859.
4
The role of economic evaluation in setting priorities for elective surgery.经济评估在确定择期手术优先级方面的作用。
Health Policy. 1993 Aug;24(3):243-57. doi: 10.1016/0168-8510(93)90044-p.
5
A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.髋关节骨关节炎全髋关节置换术的成本效益分析
JAMA. 1996 Mar 20;275(11):858-65.
6
Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative.全膝关节置换术的影响:来自骨关节炎倡议组织数据的成本效益分析
BMJ. 2017 Mar 28;356:j1131. doi: 10.1136/bmj.j1131.
7
Quality-Adjusted Life Years Gained by Hip and Knee Replacement Surgery and Its Aftercare.髋关节和膝关节置换手术及其术后护理所获得的质量调整生命年
Arch Phys Med Rehabil. 2016 May;97(5):691-700. doi: 10.1016/j.apmr.2015.12.021. Epub 2016 Jan 11.
8
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.重组活化凝血因子 VII 用于高滴度抑制物血友病患者重度膝关节手术及晚期膝关节炎的经济学评价:基于文献建模的探索性结果
Curr Med Res Opin. 2008 Mar;24(3):753-68. doi: 10.1185/030079908X273048. Epub 2008 Jan 29.
9
Estimating the quality-of-life impact and cost-effectiveness of alpha-blocker and anti-muscarinic combination treatment in men with lower urinary tract symptoms related to benign prostatic hyperplasia and overactive bladder.评估 α 受体阻滞剂和抗毒蕈碱药物联合治疗与良性前列腺增生和膀胱过度活动症相关的下尿路症状男性患者的生活质量影响和成本效益。
J Med Econ. 2012;15(3):586-600. doi: 10.3111/13696998.2012.666511. Epub 2012 Feb 24.
10
QALYs and the equity-efficiency trade-off.质量调整生命年与公平-效率权衡
J Health Econ. 1991 May;10(1):21-41. doi: 10.1016/0167-6296(91)90015-f.

引用本文的文献

1
Is total hip arthroplasty after hip arthrodesis as good as primary arthroplasty?髋关节融合术后全髋关节置换术与初次关节置换术一样好吗?
Clin Orthop Relat Res. 2011 Jul;469(7):1971-83. doi: 10.1007/s11999-010-1704-y. Epub 2010 Nov 30.
2
Valuing health States for use in cost-effectiveness analysis.评估用于成本效益分析的健康状态。
Pharmacoeconomics. 2008;26(9):769-79. doi: 10.2165/00019053-200826090-00007.
3
Using the effect size to model change in preference values from descriptive health status.使用效应量来模拟描述性健康状况下偏好值的变化。
Qual Life Res. 2004 Sep;13(7):1255-64. doi: 10.1023/B:QURE.0000037482.92757.82.
4
Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.促红细胞生成素:关于其在慢性肾衰竭中的应用及其对生活质量影响的药物经济学综述。
Pharmacoeconomics. 1993 Jan;3(1):45-82. doi: 10.2165/00019053-199303010-00006.
5
Developing the QALY concept: exploring the problems of data acquisition.发展质量调整生命年概念:探索数据获取问题。
Pharmacoeconomics. 1993 Oct;4(4):240-6. doi: 10.2165/00019053-199304040-00002.
6
Measuring the impact of menopausal symptoms on quality of life.测量更年期症状对生活质量的影响。
BMJ. 1993 Oct 2;307(6908):836-40. doi: 10.1136/bmj.307.6908.836.
7
Quality of life measurements in eating disorders, angina, and transplant candidates: are they comparable?饮食失调、心绞痛和器官移植候选者的生活质量测量:它们具有可比性吗?
J R Soc Med. 1994 Aug;87(8):441-4. doi: 10.1177/014107689408700804.
8
Reprocessing data to form QALYs.
BMJ. 1992 Aug 15;305(6850):424. doi: 10.1136/bmj.305.6850.424-a.
9
Quality of life measures in health care. III: Resource allocation.
BMJ. 1992 Nov 14;305(6863):1205-9. doi: 10.1136/bmj.305.6863.1205.
10
Reprocessing data to form QALYs.
BMJ. 1992 Aug 15;305(6850):424. doi: 10.1136/bmj.305.6850.424-b.

本文引用的文献

1
Prioritising waiting lists.
Health Trends. 1990;22(3):103-8.
2
Chiropody and the QALY: a case study in assigning categories of disability and distress to patients.足病治疗与质量调整生命年:一个为患者分配残疾和痛苦类别案例研究。
Health Policy. 1991 Jul;18(2):169-85. doi: 10.1016/0168-8510(91)90098-i.
3
Survivorship of total hip replacements.全髋关节置换术的生存率
J Bone Joint Surg Br. 1980 May;62-B(2):168-73. doi: 10.1302/0301-620X.62B2.7364829.
4
Costs and outcomes in rheumatoid arthritis and osteoarthritis.类风湿性关节炎和骨关节炎的成本与结局
Arthritis Rheum. 1984 May;27(5):522-9. doi: 10.1002/art.1780270507.
5
Discounting surgical benefits. Enucleation versus resection of the prostate.
J Med Syst. 1983 Dec;7(6):481-93. doi: 10.1007/BF00995179.
6
The natural history of untreated "prostatism".
Br J Urol. 1981 Dec;53(6):613-6. doi: 10.1111/j.1464-410x.1981.tb03273.x.
7
Charnley "low friction torque" arthroplasty. A study of long-term results.
Clin Orthop Relat Res. 1971 Nov-Dec;81:93-104. doi: 10.1097/00003086-197111000-00015.
8
Survival of knee arthroplasties. A nation-wide multicentre investigation of 8000 cases.
J Bone Joint Surg Br. 1986 Nov;68(5):795-803. doi: 10.1302/0301-620X.68B5.3782249.
9
Economics of coronary artery bypass grafting.冠状动脉搭桥术的经济学
Br Med J (Clin Res Ed). 1985 Aug 3;291(6491):326-9. doi: 10.1136/bmj.291.6491.326.
10
Cataract surgery. Outcome assessments and epidemiologic aspects.白内障手术。结果评估与流行病学方面。
Acta Ophthalmol Suppl (1985). 1985;174:3-47.